4.8 Article

Atomic View of a Toxic Amyloid Small Oligomer

Journal

SCIENCE
Volume 335, Issue 6073, Pages 1228-1231

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1213151

Keywords

-

Funding

  1. National Center for Research Resources of the NIH [RR-15301]
  2. U.S. DOE [DE-AC02-06CH11357]
  3. NIH [5T32GM008496, 1R01-AG029430]
  4. UCLA
  5. NSF [MCB-0445429]
  6. Alzheimer's Disease Research at UCLA [NIH-016570]
  7. HHMI
  8. Direct For Biological Sciences [0958111] Funding Source: National Science Foundation
  9. Div Of Molecular and Cellular Bioscience [0958111] Funding Source: National Science Foundation

Ask authors/readers for more resources

Amyloid diseases, including Alzheimer's, Parkinson's, and the prion conditions, are each associated with a particular protein in fibrillar form. These amyloid fibrils were long suspected to be the disease agents, but evidence suggests that smaller, often transient and polymorphic oligomers are the toxic entities. Here, we identify a segment of the amyloid-forming protein alpha B crystallin, which forms an oligomeric complex exhibiting properties of other amyloid oligomers: beta-sheet-rich structure, cytotoxicity, and recognition by an oligomer-specific antibody. The x-ray-derived atomic structure of the oligomer reveals a cylindrical barrel, formed from six antiparallel protein strands, that we term a cylindrin. The cylindrin structure is compatible with a sequence segment from the beta-amyloid protein of Alzheimer's disease. Cylindrins offer models for the hitherto elusive structures of amyloid oligomers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available